AU2001294959A1 - Triterpenes having antibacterial activity - Google Patents

Triterpenes having antibacterial activity

Info

Publication number
AU2001294959A1
AU2001294959A1 AU2001294959A AU9495901A AU2001294959A1 AU 2001294959 A1 AU2001294959 A1 AU 2001294959A1 AU 2001294959 A AU2001294959 A AU 2001294959A AU 9495901 A AU9495901 A AU 9495901A AU 2001294959 A1 AU2001294959 A1 AU 2001294959A1
Authority
AU
Australia
Prior art keywords
triterpenes
antibacterial activity
antibacterial
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001294959A
Other languages
English (en)
Inventor
Robert M. Carlson
Pavel A. Krasutsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Minnesota
Original Assignee
University of Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Minnesota filed Critical University of Minnesota
Publication of AU2001294959A1 publication Critical patent/AU2001294959A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AU2001294959A 2000-09-29 2001-10-01 Triterpenes having antibacterial activity Abandoned AU2001294959A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23651000P 2000-09-29 2000-09-29
US60236510 2000-09-29
PCT/US2001/030774 WO2002026762A1 (en) 2000-09-29 2001-10-01 Triterpenes having antibacterial activity

Publications (1)

Publication Number Publication Date
AU2001294959A1 true AU2001294959A1 (en) 2002-04-08

Family

ID=22889812

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001294959A Abandoned AU2001294959A1 (en) 2000-09-29 2001-10-01 Triterpenes having antibacterial activity

Country Status (3)

Country Link
US (2) US6689767B2 (US20020119935A1-20020829-C00046.png)
AU (1) AU2001294959A1 (US20020119935A1-20020829-C00046.png)
WO (1) WO2002026762A1 (US20020119935A1-20020829-C00046.png)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001294959A1 (en) * 2000-09-29 2002-04-08 Robert M. Carlson Triterpenes having antibacterial activity
US6534548B1 (en) 2001-10-02 2003-03-18 Kimberly-Clark Worldwide, Inc. Isoprenoid compositions for the inhibition of exoprotein production from gram positive bacteria
US8084046B2 (en) * 2001-10-02 2011-12-27 Kimberly-Clark Worldwide, Inc. Inhibition of exoprotein production in absorbent articles using isoprenoids
US7365221B2 (en) 2002-09-26 2008-04-29 Panacos Pharmaceuticals, Inc. Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof
WO2005021007A1 (fr) * 2003-08-28 2005-03-10 Obschestvo S Ogranichennoi Otvetstvennostju 'berezovy Mir' Prevention et traitement de l'hepatite virale b
WO2006118553A1 (en) * 2004-02-19 2006-11-09 Wutoh Anthony K Compositions comprising natural agents for the treatment of hiv-associated opportunistic infections and complications and methods for preparing and using compositions comprising natural agents
DE102004030044A1 (de) * 2004-06-22 2006-01-12 Birken Gmbh Triterpenhaltiger Oleogelbildner, triterpenhaltiges Oleogel und Verfahren zur Herstellung eines triterpenhaltigen Oleogels
JP4732454B2 (ja) * 2004-07-08 2011-07-27 ライラ ニュートラシューティカルズ 抗糖尿病性および抗炎症性を有するコロソリン酸の新規構造類似体
EP1802648A2 (en) * 2004-09-10 2007-07-04 Cornell Research Foundation, Inc. Betulinol derivatives as anti-cancer agents
TW200628161A (en) * 2004-11-12 2006-08-16 Panacos Pharmaceuticals Inc Novel betulin derivatives, preparation thereof and use thereof
WO2006133314A2 (en) * 2005-06-08 2006-12-14 Regents Of The University Of Minnesota Synthesis of betulonic and betulinic aldehydes
CA2611435C (en) * 2005-06-10 2013-01-08 Pola Chemical Industries Inc. Novel triterpenic acid derivative and preparation for external application for skin comprising the same
US20080220103A1 (en) * 2005-10-24 2008-09-11 Jay Birnbaum Method for treating/controlling/killing fungi and bacteria on living animals
JP2009512729A (ja) * 2005-10-24 2009-03-26 スタヴァル ファーマ リミテッド 菌類及び細菌を処理、抑制、殺滅する方法
FI121468B (fi) * 2006-06-07 2010-11-30 Valtion Teknillinen Betuliiniperäiset yhdisteet antimikrobisina aineina
FI20065389A (fi) * 2006-06-07 2007-12-31 Valtion Teknillinen Betuliiniperäiset yhdisteet kasvien tuholaisten syönnin estäjinä
US20080039428A1 (en) * 2006-06-29 2008-02-14 Panacos Pharmaceuticals, Inc. Antiretroviral combination therapy
CN101730706B (zh) * 2007-05-11 2015-04-15 生物科技研究有限公司 具有神经保护和增强记忆活性的受体拮抗剂
MX356760B (es) 2008-01-11 2018-06-12 Dartmouth College Triterpenoides sinteticos y metodos de uso en el tratamiento de enfermedad.
WO2009090063A1 (en) * 2008-01-16 2009-07-23 Jado Technologies Gmbh Steroid sapogenin, androstane and triterpenoid sapogenin derivatives for the treatment and prevention of infectious diseases
US7915402B2 (en) 2008-04-18 2011-03-29 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring
AU2009237579C1 (en) 2008-04-18 2016-05-12 Reata Pharmaceuticals Holdings, LLC Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
WO2009129548A1 (en) 2008-04-18 2009-10-22 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: c-17 homologated oleanolic acid derivatives
CN102066397B (zh) 2008-04-18 2013-09-11 里亚塔医药公司 包含抗炎症药效团的化合物以及使用方法
JP5383805B2 (ja) * 2008-08-15 2014-01-08 ハーキュリーズ・インコーポレーテッド クラフトパルプからの樹脂を低減させるためのパルプ化添加剤
HUE030253T2 (en) 2009-05-18 2017-04-28 Telomerase Activation Sciences Inc Preparations and methods for increasing telomerase activity
EA025568B1 (ru) 2010-12-17 2017-01-30 Рита Фармасьютикалз, Инк. Пиразолильные и пиримидинильные трициклические еноны в качестве антиоксидантных модуляторов воспаления
EA026847B1 (ru) 2011-03-11 2017-05-31 Рита Фармасьютикалз, Инк. C4-монометилтритерпеноидные производные и способы их применения
CN102603858B (zh) * 2012-03-02 2014-07-02 东北林业大学 桦木醇的含氮杂环衍生物、制备方法及用途
PE20150160A1 (es) 2012-04-27 2015-02-19 Reata Pharmaceuticals Inc Derivados de 2,2-difluoropropionamida de bardoxolona metilo, formas polimorficas y metodos de uso de los mismos
WO2013188818A1 (en) 2012-06-15 2013-12-19 Reata Pharmaceuticals, Inc. A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
US9512094B2 (en) 2012-09-10 2016-12-06 Reata Pharmaceuticals, Inc. C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
US9278912B2 (en) 2012-09-10 2016-03-08 Reata Pharmaceuticals, Inc. C13-hydroxy derivatives of oleanolic acid and methods of use thereof
UY35023A (es) 2012-09-10 2014-03-31 Reata Pharmaceuticals Inc Derivados c17-alcandiilo y alquendiilo del ácido oleanólico y sus métodos de uso
CN103768078B (zh) 2012-10-22 2019-02-05 北京大学 三萜衍生物及其抗流感用途
TW201936625A (zh) 2013-04-24 2019-09-16 美商艾伯維有限公司 甲基巴多索龍之2,2-二氟丙醯胺衍生物、其多晶形及其使用方法
CN104877015B (zh) * 2014-02-28 2019-02-01 中国人民解放军军事医学科学院毒物药物研究所 一种三萜-多肽缀合物、其药物组合物及用途
CA2998681C (en) 2015-09-23 2024-02-06 Reata Pharmaceuticals, Inc. C4-modified oleanolic acid derivatives for inhibition of il-17 and other uses
US20220296610A1 (en) * 2017-04-06 2022-09-22 Derm-Biome Pharmaceuticals Inc. Compositions and methods for treatment of infection and novel cosmeceutical preparations
RU2660649C1 (ru) * 2017-10-18 2018-07-09 федеральное государственное бюджетное образовательное учреждение высшего образования "Приволжский исследовательский медицинский университет" Министерства здравоохранения Российской Федерации Способ получения соли 3,28-дифосфата бетулина
WO2019134982A1 (en) 2018-01-04 2019-07-11 Amryt Research Limited Betulin-containing birch bark extracts and their formulation
CN108129544B (zh) * 2018-02-01 2020-10-27 云南中烟工业有限责任公司 一种具有抗微生物活性的化合物及其制备方法和应用
CN108358991B (zh) * 2018-02-01 2020-11-10 云南中烟工业有限责任公司 一种澄广花中的三萜类化合物及其制备方法和应用
CN108822179B (zh) * 2018-04-18 2020-12-22 江西农业大学 熊果酸衍生物及其制备方法和在制备治疗mrsa感染药物中的应用
CN111825738B (zh) * 2019-04-18 2023-03-14 中检科医药科技(北京)集团有限公司 桦木醇衍生物及其亲水性修饰产物，纳米溶液及其制备方法
CN115844903B (zh) * 2023-01-17 2023-05-26 潍坊赛宝工业技术研究院有限公司 白桦醇衍生物在制备抑制细菌药物中的用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559157A (en) 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
JPS6136213A (ja) * 1984-07-27 1986-02-20 Rooto Seiyaku Kk 口腔用組成物
US4820508A (en) 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US5190979A (en) * 1988-06-24 1993-03-02 Stephen Herman Ozonides of terpenes and their medical uses
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US5708163A (en) 1994-03-15 1998-01-13 Sloan-Kettering Institute Of Cancer Research Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof
US6303120B1 (en) 1994-03-15 2001-10-16 Memorial Sloan-Kettering Institute For Cancer Research Synthesis of glycoconjugates of the lewis y epitope and uses thereof
US5883074A (en) * 1995-02-08 1999-03-16 Microcide Pharmaceuticals, Inc. Potentiators of antibacterial agents
EP0902685A1 (de) 1997-01-24 1999-03-24 Marigen S.A. Ultramikroemulsionen aus spontan dispergierbaren konzentraten enthaltend antitumoral, antiviral und antiparasitär wirksame ester von pentacyclischen triterpenen
US5750578A (en) 1997-02-11 1998-05-12 Regents Of The University Of Minnesota Use of betulin and analogs thereof to treat herpesvirus infection
US6369109B1 (en) * 1998-10-28 2002-04-09 Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts Betulinic acid and derivatives thereof useful for the treatment of neuroectodermal tumor
US6303589B1 (en) 1998-12-08 2001-10-16 Micro Flo Company Pentacyclic triterpenes
US6369101B1 (en) * 1999-02-26 2002-04-09 Regents Of The University Of Minnesota Therapeutic method to treat herpes virus infection
AU2001294959A1 (en) * 2000-09-29 2002-04-08 Robert M. Carlson Triterpenes having antibacterial activity

Also Published As

Publication number Publication date
US6689767B2 (en) 2004-02-10
WO2002026762A1 (en) 2002-04-04
US20020119935A1 (en) 2002-08-29
US20040097436A1 (en) 2004-05-20

Similar Documents

Publication Publication Date Title
AU2001294959A1 (en) Triterpenes having antibacterial activity
AU4344600A (en) Antimicrobial
AU5043500A (en) Antibacterial compounds
AU4464800A (en) Modular bandage
AU2002221601A1 (en) Disinfectant
AU4344400A (en) Antimicrobial wipes
AU2001273068A1 (en) Trade allocation
AU2001228708A1 (en) Coin-validation arrangement
AU2001288040A1 (en) Homeostasis-maintaining agents
AU2002214284A1 (en) Anti-helicobacterial agents
AU3979200A (en) Antimicrobial agents
AU2001294262A1 (en) Knit design system
AU5493400A (en) Absorbent airlaid structure
AU3175900A (en) Tampon
AU6835900A (en) Deodorant
AU2001263850A1 (en) Pyrimidine-sulfonamides having endothelin-antagonist activity
AU5093700A (en) Actuator
AU2002216759A1 (en) Novel isoxazolinone antibacterial agents
AU6748500A (en) 9a-azalides with antibacterial activity
AU6892900A (en) Antibacterial amidinomethyl- and guanidinomethyl-oxazolidinones
AU2001294274A1 (en) Antibody inhibiting VPLF activity
AU5471000A (en) Antibacterial compositions
AU2001258792A1 (en) Insecticides
AU2002238493A1 (en) Antimicrobial wipe
AU2001249561A1 (en) Antimicrobial compound